Matthew Perry’s Death Darkens Ketamine’s Startup Glow
By Rolfe Winkler and Brianna AbbottDec. 16, 2023 9:00 pm ETMatthew Perry’s death from the effects of ketamine brought new...
wsjhealth
Why Your Neighborhood Pharmacy Isn’t So Friendly Anymore
CVS and Walgreens pharmacy employees say they are overworked, understaffed, and more liable to make prescription errors due to the...
WSJ News Exclusive | CVS Pulls Certain Cold Medicines From Shelves and Will Stop Selling Them
Updated Oct. 20, 2023 11:00 am ETCVS Health is pulling some of the most common decongestants from its shelves and...
New Playground, New Court, New Classroom? Thank Ozempic.
This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber...
Kaiser Permanente, Unions Reach Deal on New Contracts
Updated Oct. 13, 2023 4:49 pm ETHealth system Kaiser Permanente reached a tentative agreement with unions that would raise wages...
Pharmacy Giant Walgreens Names Tim Wentworth as New CEO
The incoming chief executive faces a tough challenge, with a core business under pressure due to pharmacy-benefit managers such as...
Striking Healthcare Workers Return to Work—Without New Contracts
Talks between Kaiser Permanente and unions are scheduled to resume Thursday, after employees temporarily walked off. Source link
Kaiser Permanente Union Workers Strike, Mounting Largest U.S. Healthcare Walkout on Record
More than 75,000 nurses, pharmacists and other employees have stopped work in a dispute over wages and staffing. Source link
WSJ News Exclusive | Health-Insurance Costs Are Taking Biggest Jumps in Years
Employers and workers are expected to see an increase of about 6.5% or higher in the cost of their health...
Illumina Names Jacob Thaysen as New CEO
Jacob Thaysen was named to the role after Francis deSouza resigned from the gene-sequencing maker in June amid a fight...
Weight-Loss Drug Wegovy Cuts Heart Attack, Stroke Risk by 20% in New Study
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a...
Biogen Buying Rare-Disease Drugmaker in $7.3 Billion Deal
The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
Eli Lilly to Acquire Obesity-Treatment Maker Versanis
Versanis shareholders could receive as much as $1.925 billion in cash, in an upfront payment and additional payments if certain...
In Battle With Microsoft, Google Bets on Medical AI Program to Crack Healthcare Industry
The search giant is fine-tuning chatbot technology via medical licensing exams. Source link
FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients
Medicare enrollees can get the anti-amyloid treatment as a result of the agency’s full approval. Source link
Deadly Fungi Are Becoming More Common And We’re Running Out of Ways to Treat Them
Research suggests fungicides are weakening antifungals before they are up for approval. Source link
No More Shots: Pill Versions of Ozempic-Like Drugs Are Coming
Tablets could appeal to people who want to lose weight but despise needles, which injections like Ozempic require. Source link
Ozempic Maker Sues Spas and Clinics Selling Custom-Made Versions
Novo Nordisk accused the firms of false advertising, trademark infringement and unfair competition. Source link
After Illumina CEO’s Fall, Other Executives Are Expected to Take Hard Look at Deals
ShareListen(2 min) Source link
